HCP, Inc. (HCP) Stake Lifted by Trillium Asset Management LLC

Trillium Asset Management LLC grew its holdings in HCP, Inc. (NYSE:HCP) by 19.7% during the first quarter, Holdings Channel reports. The fund owned 335,702 shares of the real estate investment trust’s stock after purchasing an additional 55,224 shares during the period. Trillium Asset Management LLC’s holdings in HCP were worth $10,507,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also added to or reduced their stakes in HCP. Deutsche Bank AG grew its holdings in shares of HCP by 1,073.7% during the fourth quarter. Deutsche Bank AG now owns 10,704,554 shares of the real estate investment trust’s stock valued at $298,971,000 after purchasing an additional 9,792,507 shares during the last quarter. Zimmer Partners LP acquired a new stake in HCP in the 4th quarter valued at $230,959,000. Barrow Hanley Mewhinney & Strauss LLC increased its stake in HCP by 73.8% in the 4th quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 14,036,864 shares of the real estate investment trust’s stock valued at $392,050,000 after buying an additional 5,960,734 shares during the last quarter. Cohen & Steers Inc. increased its stake in HCP by 35.0% in the 4th quarter. Cohen & Steers Inc. now owns 22,898,362 shares of the real estate investment trust’s stock valued at $639,551,000 after buying an additional 5,935,752 shares during the last quarter. Finally, Norges Bank acquired a new stake in HCP in the 4th quarter valued at $128,473,000. Institutional investors and hedge funds own 96.95% of the company’s stock.

HCP has been the topic of several recent research reports. BMO Capital Markets restated a “buy” rating and set a $33.00 price objective on shares of HCP in a research note on Wednesday, February 13th. TheStreet upgraded shares of HCP from a “c” rating to a “b-” rating in a research note on Wednesday, February 13th. Zacks Investment Research upgraded shares of HCP from a “sell” rating to a “hold” rating in a research note on Thursday, March 14th. Finally, Morgan Stanley set a $32.00 price objective on shares of HCP and gave the stock a “hold” rating in a research note on Thursday, March 28th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and nine have assigned a buy rating to the company. The company has an average rating of “Buy” and an average target price of $28.95.

Shares of HCP stock traded up $0.24 during midday trading on Wednesday, hitting $31.12. 22,529 shares of the company were exchanged, compared to its average volume of 2,822,471. The company has a market capitalization of $14.79 billion, a price-to-earnings ratio of 17.07, a PEG ratio of 6.73 and a beta of 0.43. The company has a debt-to-equity ratio of 0.90, a quick ratio of 0.80 and a current ratio of 0.80. HCP, Inc. has a 52 week low of $22.49 and a 52 week high of $32.23.

HCP (NYSE:HCP) last announced its earnings results on Wednesday, May 1st. The real estate investment trust reported $0.44 EPS for the quarter, topping the consensus estimate of $0.43 by $0.01. The business had revenue of $436.15 million during the quarter, compared to the consensus estimate of $442.20 million. HCP had a net margin of 59.96% and a return on equity of 18.05%. HCP’s revenue was down 9.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.48 EPS. Sell-side analysts forecast that HCP, Inc. will post 1.73 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, May 21st. Investors of record on Monday, May 6th will be issued a dividend of $0.37 per share. This represents a $1.48 annualized dividend and a dividend yield of 4.76%. The ex-dividend date of this dividend is Friday, May 3rd. HCP’s payout ratio is 81.32%.

In related news, Director Christine Garvey sold 3,405 shares of HCP stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $29.80, for a total transaction of $101,469.00. Following the completion of the sale, the director now owns 5,348 shares of the company’s stock, valued at approximately $159,370.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.13% of the company’s stock.

WARNING: This report was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this report on another site, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this report can be viewed at https://www.dispatchtribunal.com/2019/05/15/hcp-inc-hcp-stake-lifted-by-trillium-asset-management-llc.html.

HCP Profile

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Featured Article: What is Net Asset Value (NAV)?

Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.